ESC 365 - Efficacy, safety and clinical experience of Fimasartan in Mexican patients with essential hypertension.

Open Access

Efficacy, safety and clinical experience of Fimasartan in Mexican patients with essential hypertension.

Session: New clinical outcomes of Fimasartan

Topic: Hypertension

Speaker: Doctor A. Pavia Lopez (Mexico City, MX)

Sponsored by Boryung

Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Abel Alberto Pavia Lopez

American British Cowdray Medical Center, Mexico City (Mexico)

1 presentation

0 follower

3 more presentations in this session

New clinical outcome of Fimasartan in the elderly and diabetic chronic kidney disease.

Speaker: Doctor S. Park (Incheon, KR)

Fimasartan-based blood pressure control after acute cerebral ischemia: FABULOUS Study.

Speaker: Associate Professor W. Lee (Seongnam, KR)

Conclusion.

Speaker: Professor I. Chae (Seoul, KR) Professor S. Kim (Seoul, KR)

Access the full session

New clinical outcomes of Fimasartan

Speakers: Doctor A. Pavia Lopez, Doctor S. Park, Associate Professor W. Lee, Professor I. Chae, Professor S. Kim

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by